New Drugs FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients 6 years ago
Pharma Industry News NHS trusts to look more closely at research as a priority for improving care 6 years ago